Immune Response to Haemophilus influenzae Type b Vaccination in Patients with Chronic Renal Failure
Clinical and Vaccine Immunology, 05/30/2012
Hawdon N et al. – Adult chronic renal failure patients undergoing hemodialysis are at an increased risk of invasive Haemophilus influenzae type b (Hib) disease due to the lack of functionally active anti–Hib antibodies. The pediatric Hib polysaccharide–protein conjugate vaccine is highly immunogenic in these patients and can provide protection against invasive Hib infection for at least 1 year.